DERIACTIVE 7.5

Deriactive 7.5 contains Darifenacin 7.5 mg, an extended‑release antimuscarinic used to treat symptoms of overactive bladder, including urinary urgency, frequency, and urge incontinence . It selectively blocks M₃ receptors in the bladder to help restore control and reduce leakage 

Key Benefits:

• Reduces bladder overactivity, improving control and confidence

• Once‑daily dosing supports patient adherence 

• Selectivity minimizes unpleasant anticholinergic side effects like dry mouth and constipation